Collagen, an abundant extracellular matrix protein, has been found to have a lot of
pharmaceuticals, medicine, food, and cosmetics applications. Increased knowledge of …

Within a tumor, IL-1β is produced and secreted by various cell types, such as immune cells,
fibroblasts, or cancer cells. The IL1B gene is induced after “priming” of the cells and a …

Osteoarthritis (OA) is the most common joint disease, generating pain, disability, and
socioeconomic costs worldwide. Currently there are no approved disease-modifying drugs …

Objective: The aim of this randomized controlled study was to evaluate the efficacy of oral
native type II collagen treatment on the symptoms and biological markers of cartilage …

OBJECTIVES: The aim of this first global systematic review on selected nutraceuticals was to
synthesize and evaluate scientific relevant data available in the literature. Evidences that …

Introduction There is currently no disease-modifying drug for osteoarthritis (OA), and some
safety concerns have been identified about the leading traditional drugs. Therefore …

Background Knee osteoarthritis (OA) is a leading cause of disability among older adults.
Medical and surgical treatments are costly and associated with side effects. A natural …

Background Erosive osteoarthritis (EOA) is a commonly invoked diagnosis representing an
important variant of hand osteoarthritis (OA). There is increasing literature on the …

Osteoarthritis (OA) is the most common degenerative disease of the connective tissue of the
human musculoskeletal system. Despite its widespread prevalence, there are many …

Коллаген II типа является доминирующим в хрящевом матриксе у взрослых.
Содержание коллагена II типа в межклеточном матриксе хряща существенно …